+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Cardiovascular Devices Market - Global Forecast 2026-2032- Product Image
Cardiovascular Devices Market - Global Forecast 2026-2032- Product Image
New

Cardiovascular Devices Market - Global Forecast 2026-2032

  • PDF Icon

    Report

  • 198 Pages
  • January 2026
  • Region: Global
  • 360iResearch™
  • ID: 5336858
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The cardiovascular devices market is experiencing a transformation driven by technological advancement, changing regulatory frameworks, and the need for agile commercial strategies. Senior decision-makers must balance clinical innovation with operational efficiency to navigate new risks and accelerate growth in a highly dynamic environment.

Market Snapshot: Cardiovascular Devices Market

The global cardiovascular devices market expanded from USD 63.77 billion in 2025 to USD 68.69 billion in 2026, with a projected compound annual growth rate (CAGR) of 8.06%, ultimately reaching USD 109.79 billion by 2032. This steady growth signals intensifying demand for advanced diagnostic, monitoring, surgical, and therapeutic solutions. The sector’s momentum is propelled by digital health integration, minimally invasive procedures, and remote patient management capabilities, all of which shape both provider and patient expectations.

Scope & Segmentation

This comprehensive report dissects the factors influencing the cardiovascular devices industry and provides a framework for leadership teams to pinpoint emerging opportunities and streamline operational responses. The analysis covers critical device categories, evolving operational practices, and market-defining trends across multiple dimensions.

  • Device Types: The landscape includes diagnostic and monitoring devices such as ECG systems, event and Holter monitors, implantable loop recorders, surgical devices including stents, catheters, heart valves, vascular grafts, and therapeutic solutions like blood pressure monitors, defibrillators, and pacemakers.
  • Operational Modalities: Devices are categorized as invasive or non-invasive, necessitating tailored regulatory processes, distinct training protocols, and variable reimbursement pathways.
  • Access Methods: The use of transcutaneous and transvenous approaches affects device design, clinical integration, and workflow optimization in care delivery.
  • Clinical Applications: The scope spans cardiac rhythm management, interventions for coronary artery disease, peripheral vascular disease solutions, and products for stroke care—each segment with unique product development and clinical evidence demands.
  • End-User Environments: Devices are deployed in hospitals, clinics, ambulatory surgical centers, and increasingly in home-care settings, each requiring specific durability, ease of use, and monitoring features.
  • Regional Coverage: Analysis extends across the Americas, EMEA (Europe, Middle East, and Africa), and Asia-Pacific, reflecting regional variations in regulatory standards and health system modernization.
  • Technology Innovations: Emerging drivers include digital diagnostic platforms, enhanced device connectivity, miniaturized implants, integration of hybrid procedural techniques, and adoption of real-world evidence into clinical and commercial strategies.

Key Takeaways for Senior Decision-Makers

  • The convergence of digital diagnostics and therapy solutions is raising expectations for seamless interoperability, more robust patient involvement, and continuous health data monitoring.
  • Regulatory frameworks are shifting, with more emphasis on comprehensive evidence generation, disciplined post-market surveillance, and adaptive risk management requirements for manufacturers.
  • Supply chain stability has become central, driving adoption of multisourcing tactics, local assembly, and use of analytics to manage inventory and safeguard against disruption.
  • Evolving minimally invasive interventions are enabling expanded clinical use cases, encouraging institutions to reconsider capacity allocation and adapt care delivery models.
  • Commercial strategies are pivoting toward value-based procurement, with a focus on demonstrating measurable outcomes, cost-effectiveness, and offering targeted support across delivery settings.
  • Collaborative models, like joint development initiatives and strategic alliances, enable organizations of varying sizes to leverage synergies for faster market access and more complete product offerings.

Tariff Impact on Supply Chains and Pricing

Recent tariff adjustments in the United States bring added complexity to global supply chain management and pricing strategies within the cardiovascular device landscape. Manufacturers and suppliers are:

  • Reviewing supplier agreements, sourcing decisions, and contract terms to counteract margin pressures from tariff changes.
  • Diversifying sourcing strategies and, where needed, relocating assembly points closer to primary markets to limit cost volatility and supply risk.
  • Modifying commercial agreements to enhance flexibility and help downstream partners manage pricing volatility.
  • Reducing dependence on tariff-sensitive components to fortify overall supply chain resilience.

Cardiovascular Devices Market: Methodology & Data Sources

Primary research comprised structured interviews involving clinical leaders, developers, regulatory experts, and supply chain executives. Secondary analysis included review of peer-reviewed literature, regulatory publications, and disclosed company data. Findings were cross-validated to ensure relevance and accuracy across key markets and care settings.

Why This Report Matters

  • Enables leadership to synchronize R&D, compliance, and commercial teams for targeted growth and risk mitigation in the cardiovascular devices sector.
  • Supports benchmarking of product roadmaps against regionally specific adoption, regulatory expectations, and evolving value-based care models.
  • Guides senior management in proactively addressing emerging supply chain, regulatory, and reimbursement shifts for improved operational agility.

Conclusion

The cardiovascular devices market requires a holistic approach to strategic alignment and operational collaboration. Organizations able to integrate clinical, supply chain, and commercial strategies are better positioned to achieve sustainable value and measurable outcomes.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. Market Share Analysis, 2025
3.5. FPNV Positioning Matrix, 2025
3.6. New Revenue Opportunities
3.7. Next-Generation Business Models
3.8. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Porter’s Five Forces Analysis
4.4. PESTLE Analysis
4.5. Market Outlook
4.5.1. Near-Term Market Outlook (0-2 Years)
4.5.2. Medium-Term Market Outlook (3-5 Years)
4.5.3. Long-Term Market Outlook (5-10 Years)
4.6. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Cardiovascular Devices Market, by Device Type
8.1. Diagnostic & Monitoring Devices
8.1.1. ECG Systems
8.1.2. Electrode Leads & Accessories
8.1.3. Event Monitors
8.1.4. Holter Monitors
8.1.5. Implantable Loop Recorders
8.2. Surgical Devices
8.2.1. Cardiac Stents
8.2.2. Catheters
8.2.3. Heart Valves
8.2.4. Vascular Grafts
8.3. Therapeutic Devices
8.3.1. Blood Pressure Monitors
8.3.2. Defibrillators
8.3.3. Pacemakers
9. Cardiovascular Devices Market, by Operation Type
9.1. Invasive Devices
9.2. Non-Invasive Devices
10. Cardiovascular Devices Market, by Access Type
10.1. Transcutaneous
10.2. Transvenous
11. Cardiovascular Devices Market, by Application
11.1. Cardiac Rhythm Management
11.2. Coronary Artery Disease
11.3. Peripheral Vascular Disease
11.4. Stroke Management
12. Cardiovascular Devices Market, by End User
12.1. Ambulatory Surgical Centers
12.2. Home Care
12.3. Hospitals & Clinics
13. Cardiovascular Devices Market, by Region
13.1. Americas
13.1.1. North America
13.1.2. Latin America
13.2. Europe, Middle East & Africa
13.2.1. Europe
13.2.2. Middle East
13.2.3. Africa
13.3. Asia-Pacific
14. Cardiovascular Devices Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Cardiovascular Devices Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. United States Cardiovascular Devices Market
17. China Cardiovascular Devices Market
18. Competitive Landscape
18.1. Market Concentration Analysis, 2025
18.1.1. Concentration Ratio (CR)
18.1.2. Herfindahl Hirschman Index (HHI)
18.2. Recent Developments & Impact Analysis, 2025
18.3. Product Portfolio Analysis, 2025
18.4. Benchmarking Analysis, 2025
18.5. Abbott Laboratories
18.6. ACS Diagnostics
18.7. Alivecor, Inc.
18.8. Asahi Kasei Corporation
18.9. B. Braun SE
18.10. Baxter International Inc.
18.11. Bexen Medical
18.12. Biotronik SE & Co KG
18.13. Boston Scientific Corporation
18.14. BPL Medical Technologies Private Limited
18.15. Edwards Lifesciences Corporation
18.16. GE Healthcare
18.17. HeartFlow Holding, Inc.
18.18. Johnson & Johnson Services, Inc.
18.19. Koninklijke Philips N.V.,
18.20. Lepu Medical Technology(Beijing)Co.,Ltd.
18.21. LivaNova PLC
18.22. Medtronic PLC
18.23. Microport Scientific Corporation
18.24. Nihon Kohden Corporation
18.25. Schiller AG
18.26. Siemens Healthineers
18.27. Terumo Cardiovascular Systems Corporation
18.28. Tricog Health
18.29. Vesalius Cardiovascular Inc.
18.30. Zoll Medical Corporation
List of Figures
FIGURE 1. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 2. GLOBAL CARDIOVASCULAR DEVICES MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 3. GLOBAL CARDIOVASCULAR DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
FIGURE 4. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 5. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 6. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 7. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 9. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 11. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
FIGURE 13. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
List of Tables
TABLE 1. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 2. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 3. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 4. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 5. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 6. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 7. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY ECG SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
TABLE 8. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY ECG SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 9. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY ECG SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 10. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY ELECTRODE LEADS & ACCESSORIES, BY REGION, 2018-2032 (USD MILLION)
TABLE 11. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY ELECTRODE LEADS & ACCESSORIES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 12. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY ELECTRODE LEADS & ACCESSORIES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 13. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY EVENT MONITORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 14. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY EVENT MONITORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 15. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY EVENT MONITORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 16. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY HOLTER MONITORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 17. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY HOLTER MONITORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 18. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY HOLTER MONITORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 19. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY IMPLANTABLE LOOP RECORDERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 20. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY IMPLANTABLE LOOP RECORDERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 21. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY IMPLANTABLE LOOP RECORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 22. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 23. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 24. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 25. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2032 (USD MILLION)
TABLE 26. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY CARDIAC STENTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 27. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY CARDIAC STENTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 28. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY CARDIAC STENTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 29. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY CATHETERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 30. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY CATHETERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 31. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY CATHETERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 32. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY HEART VALVES, BY REGION, 2018-2032 (USD MILLION)
TABLE 33. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY HEART VALVES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 34. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY HEART VALVES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 35. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY VASCULAR GRAFTS, BY REGION, 2018-2032 (USD MILLION)
TABLE 36. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY VASCULAR GRAFTS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 37. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY VASCULAR GRAFTS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 38. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 39. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 40. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 41. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2032 (USD MILLION)
TABLE 42. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY BLOOD PRESSURE MONITORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 43. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY BLOOD PRESSURE MONITORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 44. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY BLOOD PRESSURE MONITORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 45. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY DEFIBRILLATORS, BY REGION, 2018-2032 (USD MILLION)
TABLE 46. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY DEFIBRILLATORS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 47. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY DEFIBRILLATORS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 48. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY PACEMAKERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 49. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY PACEMAKERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 50. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY PACEMAKERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 51. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2032 (USD MILLION)
TABLE 52. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY INVASIVE DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 53. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY INVASIVE DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 54. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY INVASIVE DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 55. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY NON-INVASIVE DEVICES, BY REGION, 2018-2032 (USD MILLION)
TABLE 56. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY NON-INVASIVE DEVICES, BY GROUP, 2018-2032 (USD MILLION)
TABLE 57. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY NON-INVASIVE DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 58. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2032 (USD MILLION)
TABLE 59. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY TRANSCUTANEOUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 60. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY TRANSCUTANEOUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 61. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY TRANSCUTANEOUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 62. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY TRANSVENOUS, BY REGION, 2018-2032 (USD MILLION)
TABLE 63. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY TRANSVENOUS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 64. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY TRANSVENOUS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 65. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 66. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY CARDIAC RHYTHM MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 67. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY CARDIAC RHYTHM MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 68. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY CARDIAC RHYTHM MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 69. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY CORONARY ARTERY DISEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 70. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY CORONARY ARTERY DISEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 71. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY CORONARY ARTERY DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 72. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY PERIPHERAL VASCULAR DISEASE, BY REGION, 2018-2032 (USD MILLION)
TABLE 73. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY PERIPHERAL VASCULAR DISEASE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 74. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY PERIPHERAL VASCULAR DISEASE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 75. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY STROKE MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
TABLE 76. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY STROKE MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
TABLE 77. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY STROKE MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 78. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 79. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
TABLE 80. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 81. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 82. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY HOME CARE, BY REGION, 2018-2032 (USD MILLION)
TABLE 83. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 84. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 85. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
TABLE 86. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
TABLE 87. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 88. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
TABLE 89. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 90. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 91. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 92. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2032 (USD MILLION)
TABLE 93. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2032 (USD MILLION)
TABLE 94. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2032 (USD MILLION)
TABLE 95. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2032 (USD MILLION)
TABLE 96. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 97. AMERICAS CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 98. NORTH AMERICA CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 99. NORTH AMERICA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 100. NORTH AMERICA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 101. NORTH AMERICA CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2032 (USD MILLION)
TABLE 102. NORTH AMERICA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2032 (USD MILLION)
TABLE 103. NORTH AMERICA CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2032 (USD MILLION)
TABLE 104. NORTH AMERICA CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2032 (USD MILLION)
TABLE 105. NORTH AMERICA CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 106. NORTH AMERICA CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 107. LATIN AMERICA CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 108. LATIN AMERICA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 109. LATIN AMERICA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 110. LATIN AMERICA CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2032 (USD MILLION)
TABLE 111. LATIN AMERICA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2032 (USD MILLION)
TABLE 112. LATIN AMERICA CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2032 (USD MILLION)
TABLE 113. LATIN AMERICA CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2032 (USD MILLION)
TABLE 114. LATIN AMERICA CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 115. LATIN AMERICA CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 116. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2032 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2032 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2032 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2032 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 125. EUROPE CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 126. EUROPE CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 127. EUROPE CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 128. EUROPE CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2032 (USD MILLION)
TABLE 129. EUROPE CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2032 (USD MILLION)
TABLE 130. EUROPE CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2032 (USD MILLION)
TABLE 131. EUROPE CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2032 (USD MILLION)
TABLE 132. EUROPE CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 133. EUROPE CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 134. MIDDLE EAST CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 135. MIDDLE EAST CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 136. MIDDLE EAST CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 137. MIDDLE EAST CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2032 (USD MILLION)
TABLE 138. MIDDLE EAST CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2032 (USD MILLION)
TABLE 139. MIDDLE EAST CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2032 (USD MILLION)
TABLE 140. MIDDLE EAST CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2032 (USD MILLION)
TABLE 141. MIDDLE EAST CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 142. MIDDLE EAST CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 143. AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 144. AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 145. AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 146. AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2032 (USD MILLION)
TABLE 147. AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2032 (USD MILLION)
TABLE 148. AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2032 (USD MILLION)
TABLE 149. AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2032 (USD MILLION)
TABLE 150. AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 151. AFRICA CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 152. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 153. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 154. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 155. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2032 (USD MILLION)
TABLE 156. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2032 (USD MILLION)
TABLE 157. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2032 (USD MILLION)
TABLE 158. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2032 (USD MILLION)
TABLE 159. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 160. ASIA-PACIFIC CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 161. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
TABLE 162. ASEAN CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 163. ASEAN CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 164. ASEAN CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 165. ASEAN CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2032 (USD MILLION)
TABLE 166. ASEAN CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2032 (USD MILLION)
TABLE 167. ASEAN CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2032 (USD MILLION)
TABLE 168. ASEAN CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2032 (USD MILLION)
TABLE 169. ASEAN CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 170. ASEAN CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 171. GCC CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 172. GCC CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 173. GCC CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 174. GCC CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2032 (USD MILLION)
TABLE 175. GCC CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2032 (USD MILLION)
TABLE 176. GCC CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2032 (USD MILLION)
TABLE 177. GCC CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2032 (USD MILLION)
TABLE 178. GCC CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 179. GCC CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 180. EUROPEAN UNION CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 181. EUROPEAN UNION CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 182. EUROPEAN UNION CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 183. EUROPEAN UNION CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2032 (USD MILLION)
TABLE 184. EUROPEAN UNION CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2032 (USD MILLION)
TABLE 185. EUROPEAN UNION CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2032 (USD MILLION)
TABLE 186. EUROPEAN UNION CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2032 (USD MILLION)
TABLE 187. EUROPEAN UNION CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 188. EUROPEAN UNION CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 189. BRICS CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 190. BRICS CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 191. BRICS CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 192. BRICS CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2032 (USD MILLION)
TABLE 193. BRICS CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2032 (USD MILLION)
TABLE 194. BRICS CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2032 (USD MILLION)
TABLE 195. BRICS CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2032 (USD MILLION)
TABLE 196. BRICS CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 197. BRICS CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 198. G7 CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 199. G7 CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 200. G7 CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 201. G7 CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2032 (USD MILLION)
TABLE 202. G7 CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2032 (USD MILLION)
TABLE 203. G7 CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2032 (USD MILLION)
TABLE 204. G7 CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2032 (USD MILLION)
TABLE 205. G7 CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 206. G7 CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 207. NATO CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 208. NATO CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 209. NATO CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 210. NATO CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2032 (USD MILLION)
TABLE 211. NATO CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2032 (USD MILLION)
TABLE 212. NATO CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2032 (USD MILLION)
TABLE 213. NATO CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2032 (USD MILLION)
TABLE 214. NATO CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 215. NATO CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 216. GLOBAL CARDIOVASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
TABLE 217. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 218. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 219. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 220. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2032 (USD MILLION)
TABLE 221. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2032 (USD MILLION)
TABLE 222. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2032 (USD MILLION)
TABLE 223. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2032 (USD MILLION)
TABLE 224. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 225. UNITED STATES CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
TABLE 226. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
TABLE 227. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
TABLE 228. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, BY DIAGNOSTIC & MONITORING DEVICES, 2018-2032 (USD MILLION)
TABLE 229. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, BY SURGICAL DEVICES, 2018-2032 (USD MILLION)
TABLE 230. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, BY THERAPEUTIC DEVICES, 2018-2032 (USD MILLION)
TABLE 231. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, BY OPERATION TYPE, 2018-2032 (USD MILLION)
TABLE 232. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, BY ACCESS TYPE, 2018-2032 (USD MILLION)
TABLE 233. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
TABLE 234. CHINA CARDIOVASCULAR DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)

Companies Mentioned

The key companies profiled in this Cardiovascular Devices market report include:
  • Abbott Laboratories
  • ACS Diagnostics
  • Alivecor, Inc.
  • Asahi Kasei Corporation
  • B. Braun SE
  • Baxter International Inc.
  • Bexen Medical
  • Biotronik SE & Co KG
  • Boston Scientific Corporation
  • BPL Medical Technologies Private Limited
  • Edwards Lifesciences Corporation
  • GE Healthcare
  • HeartFlow Holding, Inc.
  • Johnson & Johnson Services, Inc.
  • Koninklijke Philips N.V.,
  • Lepu Medical Technology(Beijing)Co.,Ltd.
  • LivaNova PLC
  • Medtronic PLC
  • Microport Scientific Corporation
  • Nihon Kohden Corporation
  • Schiller AG
  • Siemens Healthineers
  • Terumo Cardiovascular Systems Corporation
  • Tricog Health
  • Vesalius Cardiovascular Inc.
  • Zoll Medical Corporation

Table Information

Report AttributeDetails
No. of Pages198
PublishedJanuary 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 68.69 Billion
Forecasted Market Value ( USD ) by 2032 $ 109.79 Billion
Compound Annual Growth Rate8.0%
Regions CoveredGlobal
No. of Companies Mentioned27

Related Topics

Related Reports

United States Cardiovascular Devices Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033 - Product Image

United States Cardiovascular Devices Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033

  • Report
  • 125 Pages
  • United States
From
Middle East Cardiovascular Devices Market Size, Share, Growth Drivers, Trends, Opportunities & Forecast 2025-2030 - Product Image

Middle East Cardiovascular Devices Market Size, Share, Growth Drivers, Trends, Opportunities & Forecast 2025-2030

  • Report
  • 95 Pages
  • Middle East
From
Cardiovascular Devices - Global Strategic Business Report - Product Image

Cardiovascular Devices - Global Strategic Business Report

  • Report
  • 311 Pages
  • Global
From
Cardiovascular Implants Market - Global Forecast 2026-2032 - Product Image

Cardiovascular Implants Market - Global Forecast 2026-2032

  • Report
  • 181 Pages
  • Global
From
Cardiovascular Devices Market Report by Device Type, Application, End User, and Region 2025-2033 - Product Image

Cardiovascular Devices Market Report by Device Type, Application, End User, and Region 2025-2033

  • Report
  • 138 Pages
  • Global
From

About the Cardiovascular Devices Market

The Cardiovascular Devices market is a segment of the medical device industry that focuses on the diagnosis, treatment, and prevention of cardiovascular diseases. It includes a range of products such as pacemakers, stents, catheters, and other implantable devices. These devices are used to diagnose and treat conditions such as arrhythmia, heart failure, and coronary artery disease. The market is driven by factors such as the increasing prevalence of cardiovascular diseases, technological advancements, and the growing demand for minimally invasive procedures. Additionally, the rising geriatric population and the increasing awareness of cardiovascular diseases are expected to drive the market growth. Some of the major companies in the Cardiovascular Devices market include Medtronic, Abbott Laboratories, Boston Scientific Corporation, St. Jude Medical, and Johnson & Johnson. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.